脑血管病临床研究进展

Research progress of clinical study on cerebrovascular disease

我国国民经济和社会发展第十二个五年规划(简称"十二五")时期,脑血管病临床研究取得重大进展,高危非致残性脑血管事件的抗血小板治疗、规范化缺血性卒中二级预防、社区无症状性缺血性卒中流行病学调查、中药治疗缺血性卒中横断面研究、血糖对急性缺血性卒中预后的影响、缺血性卒中合并慢性肾脏病和脑微出血、缺血性脑血管病生物学标志物、线粒体脑肌病伴高乳酸血症和卒中样发作与脑萎缩、脑出血围术期血压管理、预测血管结构异常性脑出血预后量表、脑血管病流行病学调查等项研究成果分别发表于国内外重要期刊,本文拟对上述研究进展进行简要综述。

During the period of Twelfth Five-Year Plan for National Economic and SocialDevelopment, clinical study on cerebrovascular disease in China has made great progress. The results ofantiplatelet treatment in patients with high-risk non-disabling cerebrovascular events, standardizedsecondary prevention of ischemic stroke, epidemiological survey of asymptomatic ischemic stroke incommunity population, cross-sectional survey on traditional Chinese medicine for treating ischemic stroke,the impact of blood glucose on prognosis of acute ischemic stroke, ischemic stroke combined with chronickidney disease and cerebral microbleeds, biomarkers of ischemic cerebrovascular diseases, mitochondrialencephalomyopathy with lactic academia and stroke-like episodes（MELAS） and encephalatrophy,perioperative management of blood pressure in intracerebral hemorrhage, vascular structural abnormality-related intracerebral hemorrhage score（VSARICHS）, and epidemiological survey of cerebrovascular diseasein China have been published in many important journals. This paper reviewed these studies and made abrief introduction.